SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

A Q3 earnings beat, stronger-than-expected Q4 guidance and expanded share-buyback authorization sparked a sharp rally, but much of the initial gain faded during the conference call. Traders are split between seeing a potential turnaround and short squeeze, and worrying that weak underlying growth, margin pressure and managements cautious tone undermine the bullish case.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors HOPE-3 cardiac results received an American Heart Association research award, drawing bullish attention as the FDAs November 22 decision on deramiocel approaches. Traders see the award and the amended applications upper-limb data as supportive, while others stress that approval remains uncertain after the advisory committees negative vote on the cardiac indication.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers shares sold off after quarterly results missed expectations, margins compressed, and management cut its profit outlook as subscribers declined sequentially. Bears focused on weakening profitability and competition, while bulls pointed to international growth and the planned peptides launch as longer-term opportunities.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Twos looming Grand Theft Auto VI launch and managements comments that preorders are far exceeding expectations are driving attention, despite weaker quarterly bookings and unchanged bookings guidance. Bulls see the games sales and future online spending as major growth drivers, while skeptics question how much is already priced in and warn of a possible sell-the-news reaction.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCelleras quarterly update is drawing attention for better-than-expected results, positive Phase 2 data for ABCL635 in menopausal hot flashes, and expansion of its drug pipeline alongside substantial liquidity. Traders are broadly bullish on the companys shift toward developing its own clinical programs, while some stress that durability and the path to Phase 3 remain key tests.

Digital Turbine, Inc. engages in mobile growth platform solutions for advertisers, publishers, carriers, and device original equipment manufacturers. It operates through the following segments: On Device Solutions and App Growth Platform. The On Device Solutions segment consists of products and services that simplify the discovery and delivery of mobile apps and content media for device end users. The App Growth Platform segment provides Advertising Solutions and Ad Monetization Solutions. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbines quarterly results are driving attention: traders cite a revenue and adjusted-EPS beat, higher revenue guidance, and a return to GAAP profitability. The reaction is divided because margin compression, limited profit outlook improvement, debt, and accounting adjustments have fueled concern despite the growth, with some traders calling the after-hours selloff an overreaction.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

QUBTs quarterly results are driving attention, with traders focusing on stronger-than-expected revenue and rapid growth despite an earnings miss. Reactions are divided between optimism about the sales momentum and a potential rebound, and concern about ongoing losses, thin margins, and the need for stronger commercial demand.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

ASTS is drawing attention after its Rakuten Japan satellite-network joint venture, which could receive up to $1 billion in Japanese government support, and a Q3 update outlining expansion plans. Bulls focus on government and telecom demand, while skeptics cite the revenue miss, launch delays, cash burn and Blacklift execution and funding risks.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics quarterly results, featuring sharply higher revenue and raised full-year revenue and gross-margin guidance, are driving attention and optimism about Eversenses commercial traction. Traders also caution that operating losses and cash needs remain significant, and future growth depends on execution.

Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.

Iambic Therapeutics Inc.

Traders are highlighting promising updated data for Iambics IAM1363, particularly in patients previously treated with HER2-targeted therapies, along with reported insider buying. The discussion is bullish on the pipeline but tempered by skepticism and sharp post-IPO volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
